Literature DB >> 15237232

Sox genes and cancer.

C Dong1, D Wilhelm, P Koopman.   

Abstract

Sox genes encode transcription factors belonging to the HMG (High Mobility Group) superfamily. They are conserved across species and involved in a number of developmental processes. In vitro studies have shown at least one Sox gene to be capable of inducing oncogenic transformation of fibroblast cells. In addition, overexpression and/or amplification of Sox genes are associated with a large number of tumour types in vivo. We review here the available evidence linking Sox gene expression and cancer, and show that this link is supported by extensive EST database analysis. This work provides a basis for further studies aimed at investigating the possible role of Sox genes in the oncogenic process. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15237232     DOI: 10.1159/000078217

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  52 in total

1.  Identification of p27/KIP1 expression level as a candidate biomarker of response to rapalogs therapy in human cancer.

Authors:  Guang Chen; Na Yang; Xiang Wang; Si-Yuan Zheng; Yi Chen; Lin-Jiang Tong; Yi-Xue Li; Ling-Hua Meng; Jian Ding
Journal:  J Mol Med (Berl)       Date:  2010-05-28       Impact factor: 4.599

2.  The sox gene Dichaete is expressed in local interneurons and functions in development of the Drosophila adult olfactory circuit.

Authors:  Krishna V Melnattur; Daniela Berdnik; Zeid Rusan; Christopher J Ferreira; John R Nambu
Journal:  Dev Neurobiol       Date:  2012-08-23       Impact factor: 3.964

3.  dTcf/Pangolin suppresses growth and tumor formation in Drosophila.

Authors:  Shilin Song; Diana Andrejeva; Flávia C P Freitas; Stephen M Cohen; Héctor Herranz
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-24       Impact factor: 11.205

4.  Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis.

Authors:  Yang Du; Sally E Spence; Nancy A Jenkins; Neal G Copeland
Journal:  Blood       Date:  2005-06-16       Impact factor: 22.113

5.  Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer.

Authors:  De-Yuan Fu; Hao-Sheng Tan; Jin-Li Wei; Chang-Ren Zhu; Ji-Xin Jiang; Yu-Xiang Zhu; Feng-Lin Cai; Mei-Hong Chong; Chuan-Li Ren
Journal:  Tumour Biol       Date:  2015-05-14

6.  Transcriptome sequencing and annotation of the predatory mite Metaseiulus occidentalis (Acari: Phytoseiidae): a cautionary tale about possible contamination by prey sequences.

Authors:  Marjorie A Hoy; Fahong Yu; Jason M Meyer; Oscar A Tarazona; A Jeyaprakash; Ke Wu
Journal:  Exp Appl Acarol       Date:  2012-08-25       Impact factor: 2.132

7.  Structure-function relationships in human testis-determining factor SRY: an aromatic buttress underlies the specific DNA-bending surface of a high mobility group (HMG) box.

Authors:  Joseph D Racca; Yen-Shan Chen; James D Maloy; Nalinda Wickramasinghe; Nelson B Phillips; Michael A Weiss
Journal:  J Biol Chem       Date:  2014-09-24       Impact factor: 5.157

8.  Sox4 cooperates with CREB in myeloid transformation.

Authors:  Salemiz Sandoval; Christina Kraus; Er-Chieh Cho; Michelle Cho; Juraj Bies; Elena Manara; Benedetta Accordi; Elliot M Landaw; Linda Wolff; Martina Pigazzi; Kathleen M Sakamoto
Journal:  Blood       Date:  2012-05-24       Impact factor: 22.113

9.  Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.

Authors:  Lilly Y W Bourguignon; Gabriel Wong; Christine Earle; Liqun Chen
Journal:  J Biol Chem       Date:  2012-07-30       Impact factor: 5.157

10.  Evidence that SOX2 overexpression is oncogenic in the lung.

Authors:  Yun Lu; Christopher Futtner; Jason R Rock; Xia Xu; Walter Whitworth; Brigid L M Hogan; Mark W Onaitis
Journal:  PLoS One       Date:  2010-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.